ATE420364T1 - Verfahren zur magenkrebsvorhersage - Google Patents
Verfahren zur magenkrebsvorhersageInfo
- Publication number
- ATE420364T1 ATE420364T1 AT02700861T AT02700861T ATE420364T1 AT E420364 T1 ATE420364 T1 AT E420364T1 AT 02700861 T AT02700861 T AT 02700861T AT 02700861 T AT02700861 T AT 02700861T AT E420364 T1 ATE420364 T1 AT E420364T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- concentration
- galectin
- contracting
- predicting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0063868A KR100395254B1 (ko) | 2000-10-30 | 2000-10-30 | 종양 발생 예측 키트 |
PCT/KR2002/000249 WO2003071279A1 (en) | 2000-10-30 | 2002-02-19 | Method and kit for predicting cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE420364T1 true ATE420364T1 (de) | 2009-01-15 |
Family
ID=29422485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02700861T ATE420364T1 (de) | 2000-10-30 | 2002-02-19 | Verfahren zur magenkrebsvorhersage |
Country Status (7)
Country | Link |
---|---|
US (2) | US20020076738A1 (de) |
EP (1) | EP1476757B1 (de) |
KR (1) | KR100395254B1 (de) |
CN (1) | CN1325917C (de) |
AT (1) | ATE420364T1 (de) |
AU (1) | AU2002233800A1 (de) |
WO (1) | WO2003071279A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060257946A1 (en) * | 2003-06-06 | 2006-11-16 | Ciphergen Biosystems, Inc | Serum biomarkers in ischaemic heart disease |
EP1522857A1 (de) * | 2003-10-09 | 2005-04-13 | Universiteit Maastricht | Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2 |
AU2012244071B2 (en) * | 2003-10-09 | 2014-12-04 | Universiteit Maastricht | Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2 |
EP2359143A1 (de) * | 2008-10-29 | 2011-08-24 | BG Medicine, Inc. | Galectin-3-immuntest |
EP2373338B1 (de) | 2008-12-03 | 2017-02-15 | The Johns Hopkins University | Annexin a2 als immunologisches zielmolekül |
KR101343035B1 (ko) | 2008-12-22 | 2013-12-18 | 삼성전자 주식회사 | 제1수용체, 차단물질 및 제2수용체가 고정화된 고체 기판을포함하는 표적물질을 분석하기 위한 물품 및 그 용도 |
JP5702386B2 (ja) * | 2009-08-25 | 2015-04-15 | ビージー メディシン, インコーポレイテッド | ガレクチン−3および心臓再同期療法 |
CN103487588B (zh) * | 2013-09-18 | 2015-01-14 | 福建医科大学附属第一医院 | Galectin-4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用 |
WO2016024627A1 (ja) * | 2014-08-14 | 2016-02-18 | 国立大学法人広島大学 | 早産および/または低体重児出産のリスク判定方法およびそのためのキット |
WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
CN111505304A (zh) * | 2019-01-31 | 2020-08-07 | 艾维可生物科技有限公司 | 一种化学发光法检测半乳糖凝集素-3的试剂盒及使用方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801002A (en) * | 1989-01-06 | 1998-09-01 | Barbara Ann Karmanos Cancer Institute | Galactoside-binding-protein useful in the diagnosis and inhibition of of metastasis |
US5869289A (en) * | 1996-10-09 | 1999-02-09 | Incyte Pharmaceuticals, Inc. | Human galectin homolog |
US5837493A (en) * | 1997-01-23 | 1998-11-17 | Incyte Pharmaceuticals, Inc. | Human galectins |
US6146849A (en) * | 1998-06-04 | 2000-11-14 | University Of Georgia Research Foundation Inc. | Lectins and coding sequences |
US6699722B2 (en) * | 2000-04-14 | 2004-03-02 | A-Fem Medical Corporation | Positive detection lateral-flow apparatus and method for small and large analytes |
-
2000
- 2000-10-30 KR KR10-2000-0063868A patent/KR100395254B1/ko not_active IP Right Cessation
-
2001
- 2001-10-09 US US09/972,356 patent/US20020076738A1/en not_active Abandoned
-
2002
- 2002-02-19 AT AT02700861T patent/ATE420364T1/de not_active IP Right Cessation
- 2002-02-19 AU AU2002233800A patent/AU2002233800A1/en not_active Abandoned
- 2002-02-19 EP EP02700861A patent/EP1476757B1/de not_active Expired - Lifetime
- 2002-02-19 US US10/504,145 patent/US20050084915A1/en not_active Abandoned
- 2002-02-19 WO PCT/KR2002/000249 patent/WO2003071279A1/en not_active Application Discontinuation
- 2002-02-19 CN CNB028282183A patent/CN1325917C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2002233800A1 (en) | 2003-09-09 |
CN1620612A (zh) | 2005-05-25 |
WO2003071279A1 (en) | 2003-08-28 |
KR20020033246A (ko) | 2002-05-06 |
KR100395254B1 (ko) | 2003-08-21 |
EP1476757B1 (de) | 2009-01-07 |
US20050084915A1 (en) | 2005-04-21 |
US20020076738A1 (en) | 2002-06-20 |
EP1476757A1 (de) | 2004-11-17 |
EP1476757A4 (de) | 2006-04-26 |
CN1325917C (zh) | 2007-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Poole et al. | The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases | |
RU2262706C2 (ru) | Способ для диагностики атрофических гастритов | |
DE60228557D1 (de) | Candida-nachweis | |
WO2005108989A3 (en) | Assay for antibodies | |
DE60233744D1 (de) | Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper-komplexe mit elisa-tests | |
WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
RU2005119179A (ru) | Способ диагностики заболеваний путем скрининга тканей, крови или эидкостей организма животных или человека [на предмет обнаружения нефизиологических уровней]епцидина и его терапевтическое применение | |
CN110462403A (zh) | 用于区分受试者的吸烟状况的诊断测试 | |
CN104755935B (zh) | 癌症的预后和诊断方法 | |
EP3349011A1 (de) | Testverfahren für leberkrebs | |
ATE420364T1 (de) | Verfahren zur magenkrebsvorhersage | |
KR20120057562A (ko) | 피브린 및 피브리노겐 분해 생성물의 검출 및 관련된 제조 방법 및 암의 검출 및 모니터링을 위한 용도 | |
DE69941627D1 (de) | Für krebs | |
ATE258310T1 (de) | Testverfahren für collagenpeptid | |
DE60317070D1 (de) | Verfahren zur diagnose von multipler sklerose | |
EP3472199B1 (de) | Comp-peptid und antikörper dafür zur diagnose von osteoarthritis | |
DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
ATE314648T1 (de) | Diagnostisches verfahren für asthma | |
EP1245957A3 (de) | Methode zur Konzentrationsbestimmung von Ceruloplasmin in einem Blutflecken mittels enzymgekoppeltem Immunosorbent-Assay oder mittels dissoziationsverstärktem, zeitaufgelöstem Immunofluoreszenzassay, sowie Kit zum Auffinden der Wilson-Krankheit und Diagnosemethode für letztere | |
KR102372675B1 (ko) | 치주 질환 진단용 마커 단백질을 검출하는 방법 | |
US20180095090A1 (en) | Biomarkers for assessment of preeclampsia | |
JP5339227B2 (ja) | アクロレイン、インターロイキン−6及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法 | |
EP1636587A4 (de) | Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose | |
Aybay et al. | Measurement of urine albumin levels with a monoclonal antibody based in-house ELISA | |
DE50304756D1 (de) | Verfaren zur diagnose von neoplasmen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |